Related Experiment Video
Updated: Jul 8, 2025

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Cortical microstructural associations with CSF amyloid and pTau
Talia M Nir1, Julio E Villalón-Reina2, Lauren E Salminen2
1Imaging Genetics Center, Mark & Mary Stevens Neuroimaging & Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA. tnir@usc.edu.
Abstract:
Diffusion MRI (dMRI) can be used to probe microstructural properties of brain tissue and holds great promise as a means to non-invasively map Alzheimer's disease (AD) pathology. Few studies have evaluated multi-shell dMRI models such as neurite orientation dispersion and density imaging (NODDI) and mean apparent propagator (MAP)-MRI in cortical gray matter where many of the earliest histopathological changes occur in AD. Here, we investigated the relationship between CSF pTau181 and Aβ1-42 burden and regional cortical NODDI and MAP-MRI indices in 46 cognitively unimpaired individuals, 18 with mild cognitive impairment, and two with dementia (mean age: 71.8 ± 6.2 years) from the Alzheimer's Disease Neuroimaging Initiative. We compared findings to more conventional cortical thickness measures. Lower CSF Aβ1-42 and higher pTau181 were associated with cortical dMRI measures reflecting less hindered or restricted diffusion and greater diffusivity. Cortical dMRI measures, but not cortical thickness measures, were more widely associated with Aβ1-42 than pTau181 and better distinguished Aβ+ from Aβ- participants than pTau+ from pTau- participants. dMRI associations mediated the relationship between CSF markers and delayed logical memory performance, commonly impaired in early AD. dMRI metrics sensitive to early AD pathogenesis and microstructural damage may be better measures of subtle neurodegeneration in comparison to standard cortical thickness and help to elucidate mechanisms underlying cognitive decline.
Insights
Diffusion MRI (dMRI) reveals microstructural brain changes in Alzheimer's disease (AD). Advanced dMRI models better detect early AD pathology and cognitive decline than cortical thickness measures.
Area of Science:
- Neuroimaging
- Neurodegenerative Diseases
- Biomarkers
Background:
- Alzheimer's disease (AD) pathology begins in the cortex, yet early detection remains challenging.
- Diffusion MRI (dMRI) offers non-invasive insights into brain microstructural properties.
- Few studies have explored advanced multi-shell dMRI models like NODDI and MAP-MRI in the cortex for AD.
Purpose of the Study:
- To investigate the relationship between cerebrospinal fluid (CSF) biomarkers (pTau181, Aβ1-42) and cortical dMRI indices (NODDI, MAP-MRI).
- To compare the sensitivity of dMRI measures versus cortical thickness in detecting early AD-related changes.
- To explore the role of dMRI in mediating the link between AD biomarkers and cognitive performance.
Main Methods:
- Analysis of multi-shell dMRI data (NODDI, MAP-MRI) from 66 participants (cognitively unimpaired, mild cognitive impairment, dementia) in the Alzheimer's Disease Neuroimaging Initiative.
- Correlation of regional cortical dMRI indices with CSF levels of pTau181 and Aβ1-42.
- Comparison of dMRI findings with conventional cortical thickness measures and their association with logical memory performance.
Main Results:
- Lower CSF Aβ1-42 and higher pTau181 were associated with increased diffusivity and less restricted diffusion in cortical dMRI measures.
- Cortical dMRI measures showed broader associations with Aβ1-42 than pTau181 and better distinguished Aβ+ from Aβ- individuals compared to pTau status.
- dMRI associations mediated the relationship between CSF biomarkers and impaired logical memory, suggesting sensitivity to early neurodegeneration.
Conclusions:
- Advanced cortical dMRI metrics, particularly those reflecting microstructural integrity, are more sensitive to early Alzheimer's disease pathogenesis than standard cortical thickness.
- dMRI may serve as a valuable tool for elucidating mechanisms of cognitive decline in early AD and for tracking subtle neurodegeneration.
- These findings highlight the potential of dMRI for non-invasive assessment of AD-related microstructural damage.
More Related Videos
09:31Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
Related Concept Videos
Association Areas of the Cortex
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...